Cargando…

Factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-Saharan Africa: a multilevel analysis

BACKGROUND: Intermittent Preventive Treatment (IPT) of malaria in pregnancy is a full therapeutic course of antimalarial sulfadoxine-pyrimethamine (SP) medicine given to pregnant women in their second trimester at routine antenatal care visits, regardless of whether the recipient is infected with ma...

Descripción completa

Detalles Bibliográficos
Autores principales: Darteh, Eugene Kofuor Maafo, Dickson, Kwamena Sekyi, Ahinkorah, Bright Opoku, Owusu, Bernard Afriyie, Okyere, Joshua, Salihu, Tarif, Bio Bediako, Vincent, Budu, Eugene, Agbemavi, Wonder, Edjah, Jane Odurowaah, Seidu, Abdul-Aziz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529836/
https://www.ncbi.nlm.nih.gov/pubmed/34670628
http://dx.doi.org/10.1186/s13690-021-00707-z
_version_ 1784586548580188160
author Darteh, Eugene Kofuor Maafo
Dickson, Kwamena Sekyi
Ahinkorah, Bright Opoku
Owusu, Bernard Afriyie
Okyere, Joshua
Salihu, Tarif
Bio Bediako, Vincent
Budu, Eugene
Agbemavi, Wonder
Edjah, Jane Odurowaah
Seidu, Abdul-Aziz
author_facet Darteh, Eugene Kofuor Maafo
Dickson, Kwamena Sekyi
Ahinkorah, Bright Opoku
Owusu, Bernard Afriyie
Okyere, Joshua
Salihu, Tarif
Bio Bediako, Vincent
Budu, Eugene
Agbemavi, Wonder
Edjah, Jane Odurowaah
Seidu, Abdul-Aziz
author_sort Darteh, Eugene Kofuor Maafo
collection PubMed
description BACKGROUND: Intermittent Preventive Treatment (IPT) of malaria in pregnancy is a full therapeutic course of antimalarial sulfadoxine-pyrimethamine (SP) medicine given to pregnant women in their second trimester at routine antenatal care visits, regardless of whether the recipient is infected with malaria. Given the negative consequences of malaria in pregnancy, studies on Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine (IPTp-SP) are important benchmarks for understanding the extent of malaria control and prevention during pregnancy. We, therefore, examined the factors associated with the uptake of IPTp-SP among pregnant women in sub-Saharan Africa. METHODS: We used data from the current versions of the Malaria Indicators Survey of 12 countries in sub-Saharan Africa. Women aged 15–49 years participated in the surveys. The analyses were carried out using Stata version 14.2. Descriptive (frequencies and percentages) and multilevel regression analyses were carried out. The results of the multilevel regression analysis were presented as adjusted odds ratios (aOR) with 95% confidence intervals (CIs).  RESULTS: The average prevalence of uptake of IPTp-SP among pregnant women in the studied sub-Saharan African countries was 30.69%, with the highest and lowest prevalences in Ghana (59.64%) and Madagascar (10.08%), respectively. Women aged 40–44 compared to those aged 15–19 (aOR = 1.147, 95%CI = [1.02,1.30) had higher odds of receiving 3 or more doses of IPTp-SP. Women with a secondary/higher level of education compared to those with no formal education (aOR = 1.12, 95%CI = 1.04,1.20] also had higher odds of receiving 3 or more doses of IPTp-SP. Women who were exposed to malaria messages on the radio (aOR = 1.07, 95%CI = 1.02,1.12] and television (aOR = 1.13,95%CI = [1.05,1.21]) had higher odds of receiving 3 or more doses of IPTp-SP compared to those who were not exposed. CONCLUSION: Our study indicates that the uptake of IPTp-SP is relatively low among the countries included in this study, with significant inter-country variations. Higher educational level, exposure to media, low parity, and higher age group were associated with higher odds of optimal IPTp-SP uptake. National policies, programs, guidance services such as information service and counselling and other interventions aimed at improving the coverage and uptake of IPTp-SP must be targeted at women with low level of education, non-exposure to media, high parity, and younger age group to attain the desired outcome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-021-00707-z.
format Online
Article
Text
id pubmed-8529836
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-85298362021-10-25 Factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-Saharan Africa: a multilevel analysis Darteh, Eugene Kofuor Maafo Dickson, Kwamena Sekyi Ahinkorah, Bright Opoku Owusu, Bernard Afriyie Okyere, Joshua Salihu, Tarif Bio Bediako, Vincent Budu, Eugene Agbemavi, Wonder Edjah, Jane Odurowaah Seidu, Abdul-Aziz Arch Public Health Research BACKGROUND: Intermittent Preventive Treatment (IPT) of malaria in pregnancy is a full therapeutic course of antimalarial sulfadoxine-pyrimethamine (SP) medicine given to pregnant women in their second trimester at routine antenatal care visits, regardless of whether the recipient is infected with malaria. Given the negative consequences of malaria in pregnancy, studies on Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine (IPTp-SP) are important benchmarks for understanding the extent of malaria control and prevention during pregnancy. We, therefore, examined the factors associated with the uptake of IPTp-SP among pregnant women in sub-Saharan Africa. METHODS: We used data from the current versions of the Malaria Indicators Survey of 12 countries in sub-Saharan Africa. Women aged 15–49 years participated in the surveys. The analyses were carried out using Stata version 14.2. Descriptive (frequencies and percentages) and multilevel regression analyses were carried out. The results of the multilevel regression analysis were presented as adjusted odds ratios (aOR) with 95% confidence intervals (CIs).  RESULTS: The average prevalence of uptake of IPTp-SP among pregnant women in the studied sub-Saharan African countries was 30.69%, with the highest and lowest prevalences in Ghana (59.64%) and Madagascar (10.08%), respectively. Women aged 40–44 compared to those aged 15–19 (aOR = 1.147, 95%CI = [1.02,1.30) had higher odds of receiving 3 or more doses of IPTp-SP. Women with a secondary/higher level of education compared to those with no formal education (aOR = 1.12, 95%CI = 1.04,1.20] also had higher odds of receiving 3 or more doses of IPTp-SP. Women who were exposed to malaria messages on the radio (aOR = 1.07, 95%CI = 1.02,1.12] and television (aOR = 1.13,95%CI = [1.05,1.21]) had higher odds of receiving 3 or more doses of IPTp-SP compared to those who were not exposed. CONCLUSION: Our study indicates that the uptake of IPTp-SP is relatively low among the countries included in this study, with significant inter-country variations. Higher educational level, exposure to media, low parity, and higher age group were associated with higher odds of optimal IPTp-SP uptake. National policies, programs, guidance services such as information service and counselling and other interventions aimed at improving the coverage and uptake of IPTp-SP must be targeted at women with low level of education, non-exposure to media, high parity, and younger age group to attain the desired outcome. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13690-021-00707-z. BioMed Central 2021-10-21 /pmc/articles/PMC8529836/ /pubmed/34670628 http://dx.doi.org/10.1186/s13690-021-00707-z Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Darteh, Eugene Kofuor Maafo
Dickson, Kwamena Sekyi
Ahinkorah, Bright Opoku
Owusu, Bernard Afriyie
Okyere, Joshua
Salihu, Tarif
Bio Bediako, Vincent
Budu, Eugene
Agbemavi, Wonder
Edjah, Jane Odurowaah
Seidu, Abdul-Aziz
Factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-Saharan Africa: a multilevel analysis
title Factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-Saharan Africa: a multilevel analysis
title_full Factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-Saharan Africa: a multilevel analysis
title_fullStr Factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-Saharan Africa: a multilevel analysis
title_full_unstemmed Factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-Saharan Africa: a multilevel analysis
title_short Factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-Saharan Africa: a multilevel analysis
title_sort factors influencing the uptake of intermittent preventive treatment among pregnant women in sub-saharan africa: a multilevel analysis
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8529836/
https://www.ncbi.nlm.nih.gov/pubmed/34670628
http://dx.doi.org/10.1186/s13690-021-00707-z
work_keys_str_mv AT darteheugenekofuormaafo factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT dicksonkwamenasekyi factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT ahinkorahbrightopoku factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT owusubernardafriyie factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT okyerejoshua factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT salihutarif factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT biobediakovincent factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT budueugene factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT agbemaviwonder factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT edjahjaneodurowaah factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis
AT seiduabdulaziz factorsinfluencingtheuptakeofintermittentpreventivetreatmentamongpregnantwomeninsubsaharanafricaamultilevelanalysis